Izabela Pieniążek

ORCID: 0000-0002-9779-696X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Mental Health Treatment and Access
  • Antibiotic Use and Resistance
  • Mechanical Circulatory Support Devices
  • Mental Health and Psychiatry
  • Pneumonia and Respiratory Infections
  • Inhalation and Respiratory Drug Delivery
  • Respiratory viral infections research
  • Antibiotic Resistance in Bacteria
  • Cardiac pacing and defibrillation studies
  • Treatment of Major Depression
  • SARS-CoV-2 detection and testing
  • Prostate Cancer Treatment and Research
  • Family Caregiving in Mental Illness
  • Chronic Lymphocytic Leukemia Research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pharmacological Effects and Toxicity Studies
  • Obsessive-Compulsive Spectrum Disorders
  • Cardiac Structural Anomalies and Repair
  • Cervical Cancer and HPV Research
  • Acute Lymphoblastic Leukemia research
  • Hepatitis B Virus Studies
  • Attention Deficit Hyperactivity Disorder
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Cardiac Valve Diseases and Treatments

Infections caused by resistant Gram-negative bacteria are becoming increasingly common and now pose a serious public health threat worldwide, because they difficult to treat due few treatment options associated with high morbidity mortality. The combination of ceftazidime the beta-lactamase inhibitor avibactam - seems be right choice in this situation. aim study was evaluate activity ceftazidime/avibactam other commonly used antibiotics against Enterobacterales Pseudomonas aeruginosa strains...

10.2147/idr.s344165 article EN cc-by-nc Infection and Drug Resistance 2022-03-01

Patients with severe heart failure (HF), who are not eligible for cardiac transplantation and receive optimal medical management, based mainly on the use of pharmacological treatment devices such as resynchronization therapy (implantable cardioverter-defibrillator), achieve poor clinical outcomes constitute a group extremely prognosis. Currently, technology used in latest generation left ventricular assist (LVADs), HeartMate 3, makes it possible to patient survival at level obtained by...

10.5603/cj.a2020.0148 article EN cc-by-nc-nd Cardiology Journal 2020-11-03

The purpose was to estimate the financial consequences of reimbursement dasatinib in adult population with Ph+ ALL resistance or intolerance prior therapy Poland. budget impact model developed evaluate consequence for National Health Fund Poland case dasatinib. Two scenarios were considered: and without two-years’ time horizon (2015-2016). In scenario reimbursement, would be used instead FLAM chemotherapy (fludarabine, cytarabine, mitoxantrone). Based on Polish epidemiological data target –...

10.1016/j.jval.2015.09.2412 article EN publisher-specific-oa Value in Health 2015-10-20

Objective: Schizophrenia is a serious public health problem: it affects approximately 1% of world’s population and leading cause disability. The main objective was to develop report concerning burden schizophrenia with special attention negative symptoms in seven Central Eastern European countries. Methods: project consisted two phases: literature review retrospective data collection. involved search for published international databases country-specific from local sources relation to:...

10.7365/jhpor.2013.4.5 article EN cc-by Journal of Health Policy & Outcomes Research 2013-12-31

The outbreak of the COVID-19 pandemic presented world with many new challenges such as rapid and accurate diagnosis infected individuals. RT-PCR has become gold standard in diagnostics, but its limitations are: long turnaround time need to be conducted by specialized staff. for easy-to-use diagnostic tests led development ID NOW — a molecular test that provides less than 15 minutes can performed support staff point-of-care (POC) locations. It also detect other infections similar symptoms,...

10.5114/aoms/158535 article EN cc-by-nc-sa Archives of Medical Science 2023-01-14
Coming Soon ...